We have observed
8 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after May 20, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
DETECTION OF DIAGNOSTIC PEPTIDES
BIOCHEMICAL MARKERS FOR CVD RISK ASSESSMENT
PRESSURE RESISTING BARRIER WALLS
Neutron scintillation detector
Cultured cartilage tissue material
ASSAY FOR A TYPE II COLLAGEN BIOMARKER
ANALYSIS OF EEG SIGNALS TO DETECT HYPOGLYCAEMIA
Production method of tissue regeneration material and tissue regeneration material